Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently.

Wilcox MA, Hardin J, Weaver J, Voss EA.

Pharmaceut Med. 2019 Oct;33(5):389-394. doi: 10.1007/s40290-019-00294-z.

PMID:
31933226
2.

Criteria2Query: a natural language interface to clinical databases for cohort definition.

Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, Makadia R, Jin P, Shang N, Kang T, Weng C.

J Am Med Inform Assoc. 2019 Apr 1;26(4):294-305. doi: 10.1093/jamia/ocy178.

3.

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL.

Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.

4.

A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis.

Marini NJ, Hoffmann TJ, Lammer EJ, Hardin J, Lazaruk K, Stein JB, Gilbert DA, Wright C, Lipzen A, Pennacchio LA, Carmichael SL, Witte JS, Shaw GM, Rine J.

PLoS One. 2011;6(11):e28408. doi: 10.1371/journal.pone.0028408. Epub 2011 Nov 30.

5.

Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer.

Punnen S, Hardin J, Cheng I, Klein EA, Witte JS.

PLoS One. 2011;6(11):e27711. doi: 10.1371/journal.pone.0027711. Epub 2011 Nov 23.

6.

Impact of consumption of vegetable, fruit, grain, and high glycemic index foods on aggressive prostate cancer risk.

Hardin J, Cheng I, Witte JS.

Nutr Cancer. 2011;63(6):860-72. doi: 10.1080/01635581.2011.582224. Epub 2011 Jul 20.

7.

Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer.

Reese AC, Hardin J, Cheng I, Casey G, Witte JS.

Pharmaceuticals (Basel). 2010 Oct 8;3(10):3127-3142.

8.

Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.

Wessel J, McDonald SM, Hinds DA, Stokowski RP, Javitz HS, Kennemer M, Krasnow R, Dirks W, Hardin J, Pitts SJ, Michel M, Jack L, Ballinger DG, McClure JB, Swan GE, Bergen AW.

Neuropsychopharmacology. 2010 Nov;35(12):2392-402. doi: 10.1038/npp.2010.120. Epub 2010 Aug 25.

9.

Longitudinal genetic analysis of brain volumes in normal elderly male twins.

Lessov-Schlaggar CN, Hardin J, DeCarli C, Krasnow RE, Reed T, Wolf PA, Swan GE, Carmelli D.

Neurobiol Aging. 2012 Apr;33(4):636-44. doi: 10.1016/j.neurobiolaging.2010.06.002. Epub 2010 Jul 13.

10.

Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample.

Hardin J, He Y, Javitz HS, Wessel J, Krasnow RE, Tildesley E, Hops H, Swan GE, Bergen AW.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3399-406. doi: 10.1158/1055-9965.EPI-09-0960.

11.

Whole genome microarray analysis, from neonatal blood cards.

Hardin J, Finnell RH, Wong D, Hogan ME, Horovitz J, Shu J, Shaw GM.

BMC Genet. 2009 Jul 22;10:38. doi: 10.1186/1471-2156-10-38.

12.

Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings.

Madhivanan P, Krupp K, Hardin J, Karat C, Klausner JD, Reingold AL.

Trop Med Int Health. 2009 Jun;14(6):703-8. doi: 10.1111/j.1365-3156.2009.02274.x. Epub 2009 Apr 20.

13.

Trends in the probability of twins and males in California, 1983-2003.

Hardin J, Carmichael SL, Selvin S, Shaw GM.

Twin Res Hum Genet. 2009 Feb;12(1):93-102. doi: 10.1375/twin.12.1.93.

PMID:
19210184
14.

The estimated probability of dizygotic twins: a comparison of two methods.

Hardin J, Selvin S, Carmichael SL, Shaw GM.

Twin Res Hum Genet. 2009 Feb;12(1):79-85. doi: 10.1375/twin.12.1.79.

PMID:
19210182

Supplemental Content

Loading ...
Support Center